RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Visiomed Group ROE 2024

Visiomed Group ROE

-0.22

Visiomed Group Dividend yield

Ticker

ALVMG.PA

ISIN

FR0013481835

WKN

A2PZ7S

In 2024, Visiomed Group's return on equity (ROE) was -0.22, a -31.34% increase from the -0.32 ROE in the previous year.

Visiomed Group Aktienanalyse

What does Visiomed Group do?

The Visiomed Group SA, based in France and founded in 2007, is a globally operating company specializing in the development and distribution of medical devices and healthcare products. With a wide range of innovative medical devices and technologies, Visiomed has become a leading provider in this field. The business model of Visiomed is based on developing innovative technologies in the healthcare sector and bringing them to the global market. The company specifically invests in research and development as well as building strategic partnerships and distribution networks. Visiomed has divided itself into different sectors to offer its customers a broad range of healthcare products. The core areas of the company are Connected Health, Medical Care, and Oral Care. The Connected Health sector combines activities in the digital healthcare services and offers innovative solutions for monitoring and improving health. These include products such as ThermoFlash, the contactless infrared thermometer for measuring body temperature, or Bewell Connect, the system for monitoring blood pressure, pulse, and weight. In the Medical Care sector, Visiomed offers devices for medical diagnostics, therapy, and care. These include products such as the electronic stethoscope Stet-o-mate, the X'traseal wound care system, and the cable ECG Easy ECG. The Oral Care sector includes products for oral and dental care. These include the ZenCare electric ultrasonic toothbrush head, the OralJet tongue cleaner, and the Teeth Whitener teeth whitening set. Visiomed is proud to offer a variety of healthcare products tailored to the needs of consumers and professionals alike. The company is dedicated to providing its customers with innovative and effective solutions to improve healthcare worldwide. Visiomed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Visiomed Group's Return on Equity (ROE)

Visiomed Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Visiomed Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Visiomed Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Visiomed Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Visiomed Group Stock

What is the ROE (Return on Equity) of Visiomed Group this year?

The ROE of Visiomed Group this year is -0.22 undefined.

How has the Return on Equity (ROE) of Visiomed Group developed compared to the previous year?

The ROE of Visiomed Group has increased by -31.34% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Visiomed Group?

A high ROE indicates that Visiomed Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Visiomed Group?

A low ROE can indicate that Visiomed Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Visiomed Group affect the company?

A change in ROE (Return on Equity) of Visiomed Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Visiomed Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Visiomed Group?

Some factors that can influence Visiomed Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Visiomed Group pay?

Over the past 12 months, Visiomed Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Visiomed Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Visiomed Group?

The current dividend yield of Visiomed Group is .

When does Visiomed Group pay dividends?

Visiomed Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Visiomed Group?

Visiomed Group paid dividends every year for the past 0 years.

What is the dividend of Visiomed Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Visiomed Group located?

Visiomed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Visiomed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Visiomed Group from 4/28/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/28/2024.

When did Visiomed Group pay the last dividend?

The last dividend was paid out on 4/28/2024.

What was the dividend of Visiomed Group in the year 2023?

In the year 2023, Visiomed Group distributed 0 EUR as dividends.

In which currency does Visiomed Group pay out the dividend?

The dividends of Visiomed Group are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Visiomed Group

Our stock analysis for Visiomed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Visiomed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.